Stock Taper
SCREENER COMPARE ANY 2 STOCKS
HALO
HALOZYME THERAPEUTICS, INC.
NASDAQ
$105.35
▼ DOWN 1.47% (-1.57)

KEY STATISTICS

Market Cap$12.50 B
52w High$109.66
52w Low$61.23
Dividend Yield—
Frequency—
P/E19.65
Volume1.68M
Shares Out.118.61M

COMPANY

LEADERSHIP

Helen I. Torley
CHIEF EXECUTIVE
Helen I. Torley

COMPENSATION 2026

Salary$1,000,000
Stock Awards$19,350,145
Incentive Plan Pay$1,147,500
All Other Comp.$18,564
Total$23,166,223

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 16, 2004
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
423

PRICE TARGET

Target High$115.00
Target Low$90.00
Target Median$105.00
Target Consensus$103.00

UPCOMING EARNINGS

DateNov 2, 2026
DayMonday
Rev. Est.$482.28M
NOV
2
MON

PRICE

$105.35 ▼ DOWN 1.47% (−$1.57)
$105$106$1079:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM105.35

About Halozyme Therapeutics, Inc.

https://www.halozyme.com ↗

Halozyme Therapeutics develops ENHANZE-based drug delivery technologies and collaborates globally to enhance biologic and small molecule therapies for cancer, immunology, and infectious diseases.

INDUSTRY

Biotechnology

A SERVICE HALOZYME THERAPEUTICS, INC. IS KNOWN FOR

ENHANZE® drug delivery technology

A technology platform using proprietary enzyme rHuPH20 that enables subcutaneous delivery of injectable drugs, licensed to pharma companies to improve convenience, reduce treatment burden, and enhance patient experience.

COMPETITORS

COMPETITOR
PCRX COMPARE
WST COMPARE
XERS COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q4-2025Q1-2026Q2-2026
Royalty$205.64M $494.01M ▲$240.68M ▼$307.7M ▲
Product$179.3M $42.94M ▼$265.8M ▲$234.3M ▼
Bulk rHuPH20$23.27M — $73.5M ▲$59.62M ▼
Collaborative Agreements$38.57M $95.13M ▲$5.6M ▼$43.67M ▲
Upfront Fees— — — $35.5M
Salesbased Milestone$10M — — —

Revenue by Geography

MapREGIONFY2015FY2016FY2017FY2018
SWITZERLAND$57.14M $93.07M ▲$119.14M ▲$109.89M ▼
UNITED STATES$77.15M $52.29M ▼$196.27M ▲$40.48M ▼
Foreign countries$772K $1.33M ▲— —

ETFS HOLDING THIS STOCK

ETFS HOLDING
296
LISTED HERE
26
RANKED BY POSITION SIZE
XUU.TO
0.02% · 4.1M
VTI
0.01% · 3.8M
XBI
1.35% · 1.5M
FBT
4.25% · 1.2M
SCHA
0.26% · 562.9K
DFAS
0.22% · 328.1K
VETS
2.15% · 286.1K
CSMD
3.59% · 162.5K
JMEE
0.58% · 162.3K
JSMD
1.50% · 151.8K
PBE
3.51% · 134.0K
JHMM
0.15% · 87.8K
GR
GRNJ
1.61% · 78.3K
FSMD
0.27% · 65.7K
FLQM
0.44% · 65.4K
CANC
3.15% · 63.2K
CLSE
0.74% · 62.2K
SFLO
0.81% · 60.8K
LABU
0.92% · 54.6K
TMSL
0.17% · 46.9K
EZM
0.50% · 44.8K
AVUS
0.03% · 40.5K
ROE
1.42% · 38.4K
QGRO
0.18% · 35.8K
VALT
1.13% · 28.3K
LSAT
4.26% · 26.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
90.47%
HOLDERS
942
TOP 12 OF 942 · RANKED BY POSITION SIZE
Dld Asset Management, LP
30.0M sh · $42.34M
Blackrock Inc.
17.6M sh · $922.58M
Blackrock, Inc.
13.3M sh · $1.04B
Vanguard Group Inc
11.6M sh · $852.93M
Bb Biotech AG
8.3M sh · $134M
State Street Corp
5.2M sh · $405.38M
Blackrock Fund Advisors
5.1M sh · $50.3M
Invesco Ltd.
4.0M sh · $259.33M
Arrowstreet Capital, Limited Partnership
3.3M sh · $241.34M
Blackrock Institutional Trust Company, N.A.
3.0M sh · $29.99M
Ubs Group AG
2.9M sh · $216.04M
Bank Of America Corp /De/
2.9M sh · $188.27M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Sale (Partial)
2025-03-24
 Josh Gottheimer
Josh Gottheimer
Sale (Partial)
2024-09-09
 Daniel Goldman
Daniel Goldman
Sale
2023-07-12
SENATE TRADES
Mark Warner
Mark Warner
Sale (Full)
2017-11-06

INSIDER TRADES

★
DIRECTOR:
Appelhans Dannielle
— · —
2026-08-14
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Torley Helen
Sale · 9.6K shares
2026-08-19
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Torley Helen
Sale · 900 shares
2026-08-17
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Torley Helen
Sale · 3.2K shares
2026-08-19

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
NEUTRAL 2
OUTPERFORM 1
MARKET OUTPERFORM 1
EQUAL WEIGHT 1
OVERWEIGHT 1
9 GRADES IN THE LAST 12 MONTHS
Leerink Partners OUTPERFORM Citizens MARKET OUTPERFORM Wells Fargo EQUAL WEIGHT HC Wainwright & Co. BUY TD Cowen BUY Morgan Stanley OVERWEIGHT Benchmark BUY Goldman Sachs NEUTRAL

SECTORS PEERS

PEERPRICE
JAZZ$244.54COMPARE
CORT$113.88COMPARE
HSIC$89.52COMPARE
CYTK$72.09COMPARE
ATR$132.99COMPARE
ABVX$113.35COMPARE
RYTM$107.17COMPARE
CAI$25.63COMPARE